Webinar | November 19, 2024

Implementing PIC/S Annex 1: Contamination Control Strategy With QRM Principles

Quality control assurance satisfaction-GettyImages-2117357383

Delve into the evolving requirements for Contamination Control Strategies (CCSs) within highly regulated industries, particularly focusing on the updated EU GMP and PIC/S Annex 1 guidelines. While CCS has long been a core concept, recent revisions emphasize the integration of Quality Risk Management (QRM) principles into the implementation of these strategies. This webinar provides a comprehensive overview of the key components and regulatory expectations of CCS, with an emphasis on contamination control’s role in safeguarding product quality, safety, and regulatory compliance in sectors like pharmaceuticals, biologics, and advanced therapies (e.g., cell and gene therapies).

The presentation addresses contamination control fundamentals, including risk mitigation, hazard identification, and how these elements align with QRM principles. The discussion also highlights the importance of Process Risk Management, focusing on comprehensive risk assessments across the entire production process, a critical aspect of the revised ICH Q9(R1). Understanding the connection between risk assessments and CCS is crucial for maintaining regulatory alignment and ensuring product integrity.

Gain the knowledge to effectively document, document, and implement contamination control measures in compliance with regulatory standards.

access the Webinar!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online